Evosep develops technologies and solutions for protein-based clinical diagnostics, focusing on making sample separation faster and more robust than existing alternatives.

Evosep

Evosep One

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.

We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic.
 
We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.

Vaekstfonden

Novo Holdings

Evosep Biosystems

Next stop: The Evosep HQ in #Odense
 
Join Camilla, Joel, Magnus, and Maurine from Evosep as we take part in the Bruker eXceed Nordic Seminars Tour.
 
On September 5th we are happy to host the Bruker Daltonics eXceed event at our HQ and share insights on the latest breakthroughs in #proteomics and #lifescience research.
 
This is a great opportunity to connect, learn, and drive #innovation together as we push boundaries in proteomics.
 
Don't miss out. Secure your seat here: https://lnkd.in/eNYFm_UR

What a night! 

Together with, friends, colleagues and collaborators we celebrated the grand opening of our new facility. It was a fantastic evening filled with great company and a shared excitement for the future so thank you to everyone who joined us to toast to new beginnings. 

This move marks a significant milestone for us and we’re thrilled to be expanding our production and laboratory capacities in this state-of-the-art facility. With lots and lots of space and close proximity to key institutions like the Syddansk Universitet - University of Southern Denmark and the new University Hospital, we are excited to continue our commitment to making proteomics more accessible and efficient for all. 

A special thanks to Peter Rahbæk Juel, the Mayor of Odense, for adding a touch of ceremony—and a bit of fun—to our event. He teamed up with Morten Bern and Ole Vorm, to cut the official ribbon! 

#biotech #lifescience #madeinodense #proteomics

Viral infections are usually diagnosed with PCR or immunoassays. This study introduces vPro-MS, a proteomics workflow for untargeted virus identification from patient samples. Using a peptide library covering 331 viruses, vPro-MS enables high-throughput analysis with >99.9% specificity. It offers sensitivity comparable to metagenomics, allowing large-scale virus detection in biofluids like human plasma. #proteomics #patientsample #bloodplasma

Read the study here: https://lnkd.in/d-rCBfSU

Evosep is at #IMSC2024! 
Join us at booth 04 to discover how our innovative proteomics solutions can revolutionize your research. Also, don't miss our lunch seminar! We still have seats available for our lunch seminar with Prof. Jesper Velgaard Olsen and Prof Birgit Schilling on Wednesday. 
Registration details in the comments below.
#proteomics #research #massspectrometry #melbourne

Say hello to Tina Ebbesen, the newest member of our team.
 
Tina holds a master’s degree in Intercultural Marketing from Copenhagen Business School and specializes in social events and branding. At Evosep, she will be managing our presence at industry conferences and strengthening our promotional campaigns.
 
Please join us in giving Tina a warm welcome to Evosep!
#proteomics #evosep #team #lcms

Building a strong team goes beyond the office walls. Taking time to connect with colleagues outside of work not only strengthens team spirit but also fosters a healthier, more vibrant work environment. 

Yesterday, we put this into practice when the team ran the annual DHL relay race in Odense. It was a great evening of running together, challenging ourselves, and building team spirit. #proteomics #team #lcms

Metric
Company Name	Evosep
Symbol
MSH ID	COM:EVOSEP
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology and Scientific Instruments
Country	DK
Stage
Employee Count	74
Website	evosep.com
LinkedIn	evosep-biosystems
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

EVOS

COM:EVOSEP

Evosep

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue